More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control ...

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why HIV leads to different outcomes in different people. The research was ...

A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make protective antibodies against HIV.

Explore the latest advancements in HIV therapy and how enhanced immune cells can improve treatment outcomes for patients.

So far, there is no "magic bullet" to cure HIV for good, but scientists are making rapid progress.

Groundbreaking study led by Weizmann Institute of Science and Hadassah AIDS Center scientists paves the way for new medical ...

As a part of its life cycle, human immunodeficiency virus-1 (HIV-1) inserts a copy of its DNA into human immune cells. Some of these newly infected immune cells can then transition into a dormant, ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible for ...

Left: Structure of the Human Immunodeficiency Virus (HIV). Note the envelope protein that protects the virus against immunological detection and the small genome consisting of two short strands of RNA ...

A sixth person, dubbed the “Geneva patient,” may be free of HIV after receiving a stem cell transplant intended to treat another disease—his cancer. The man, who was diagnosed with HIV in 1990, ...